Riabov V, Xu Q, Schmitt N, Streuer A, Ge G, Bolanos L, Wunderlich M, Jann J-C, Wein A, Altrock E, Demmerle M, Mukherjee S, Ali AM, Rapp F, Nowak V, Weimer N, Obländer J, Palme I, Göl M, Jawhar A, Darwich A, Wuchter P, Weiss C, Raza A, Foulks JM, Starczynowski DT, Yang F-C, Metzgeroth G, Steiner L, Jawhar M, Hofmann W-K, Nowak D. ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms. haematol [Internet]. 2024May1 [cited 2026May10];109(5):1426-38. Available from: https://haematologica.org/article/view/haematol.2023.282921